NURS 6521: Advanced PharmacologyWEEK 5 INITIAL POSTNeurological SystemNeurological disorders can present several complications for patients of all ages. Patientswith neurological disorders need to be effectively managed as these disorders may drastically affect their lives. Treatments for nervous system disorders present unique issues not just becauseof the scope and breadth of the disorders, but also because the types of drugs that are often used for treatment (Arcangelo and Peterson, 2013). The advanced practice nurse is responsible to manage the diagnosis, treatment, and education of patients with neurological disorders. The following discussion will include a description of depression, including the types of drugs that would be prescribed to treat symptoms of depression, how age impacts the effects of prescribed drugs, and how to reduce negative side effects.DepressionMajor depressive disorder (MDD) is defined as "a mood disorder characterized by alterations in cognition, behavior, and physical functioning" (Arcangelo and Peterson, 2013, p. 617). Depression affects approximately 151 million individuals worldwide (Arcangelo and Peterson, 2013). There is no one single causative factor identified for the depression; therefore, it is thought to be multifactorial, among numerous physiologic, social, genetic, environmental, and biochemical factors (Arcangelo and Peterson, 2013). Initial onset of depression can occur any time throughout a lifespan, but the peak onset is considered to be during the fourth decade oflife (Belmaker and Agam, 2008). The Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) established criteria for the diagnosis of depression. The diagnosis of major depressive disorder requires "a
distinct change of mood, characterized by sadness or irritability and accompanied by at least several psychophysiological changes, such as disturbances in sleep, appetite, or sexual desire; constipation; loss of the ability to experience pleasure in work or with friends; crying; suicidal thoughts; and slowing of speech and action" (Belmaker and Agam, 2008, p. 55). These changes must last a minimum of 2 weeks and interfere considerably with work and family relations.
You've reached the end of your free preview.
Want to read all 5 pages?
- Fall '13
- Selective serotonin reuptake inhibitor, Major depressive disorder, Antidepressant, Arcangelo